Eterna Therapeutics Inc. (NASDAQ: ERNA) Stock Information | RedChip

Eterna Therapeutics Inc. (NASDAQ: ERNA) Listen to this Section


$1.73
N/A ( 0% ) 1.7K

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Market Data


Open


$1.73

Previous close


$1.73

Volume


1.7K

Market cap


$9.31M

Day range


$1.71 - $1.77

52 week range


$0.84 - $2.63

Insider Ownership Transactions

Total Amount Purchased: 3,710,949.00 | $ 6,419,941.77

Date Type Amount Purchased Purchaser
2024-06-25 Sale -437.00 Gurrola Sandra M
2024-04-29 Sale -88946.00 Cicala Peter
2024-04-29 Sale -80000.00 Gurrola Sandra M
2024-04-29 Sale -124525.00 Bristol James Arthur
2024-01-03 Sale -1685218.00 Luther Sanjeev
2024-01-03 Sale -168521.00 Clarke Dorothy J
2023-12-20 Buy 3125976.00 Cherington Charles
2023-12-18 Buy 424928.00 Freebird Partners LP
2023-08-25 Buy 2307692.00 Cherington Charles
2023-08-10 Sale 0.00 WAGNER RICHARD W

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 84 Aug 13, 2024
4 Insider transactions 1 Jun 25, 2024
10-q Quarterly Reports 77 May 14, 2024
4 Insider transactions 1 Apr 29, 2024
4 Insider transactions 1 Apr 29, 2024
4 Insider transactions 1 Apr 29, 2024
8-k 8K-related 13 Mar 22, 2024
10-k/a Quarterly Reports 17 Mar 18, 2024
10-k Annual reports 113 Mar 14, 2024
8-k 8K-related 14 Feb 16, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.